Insurance - Brokers
Compare Stocks
5 / 10Stock Comparison
EHTH vs UNH vs CVS vs ELV vs CI
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
EHTH vs UNH vs CVS vs ELV vs CI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Brokers | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $58M | $335.60B | $111.40B | $80.98B | $74.85B |
| Revenue (TTM) | $529M | $449.71B | $407.90B | $200.41B | $277.94B |
| Net Income (TTM) | $20M | $12.04B | $2.93B | $5.24B | $6.29B |
| Gross Margin | 82.8% | 18.8% | 13.9% | 23.2% | 9.3% |
| Operating Margin | 11.1% | 4.2% | 1.5% | 3.8% | 3.4% |
| Forward P/E | — | 20.2x | 12.2x | 13.9x | 9.4x |
| Total Debt | $134M | $78.39B | $93.59B | $33.23B | $31.46B |
| Cash & Equiv. | $74M | $24.36B | $8.51B | $9.49B | $7.68B |
EHTH vs UNH vs CVS vs ELV vs CI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| eHealth, Inc. (EHTH) | 100 | 1.4 | -98.6% |
| UnitedHealth Group … (UNH) | 100 | 121.3 | +21.3% |
| CVS Health Corporat… (CVS) | 100 | 133.2 | +33.2% |
| Elevance Health Inc. (ELV) | 100 | 126.8 | +26.8% |
| Cigna Corporation (CI) | 100 | 143.9 | +43.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EHTH vs UNH vs CVS vs ELV vs CI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EHTH has the current edge in this matchup, primarily because of its strength in quality and dividends.
- Combined ratio 0.9 vs CVS's 1.0 (lower = better underwriting)
- 10.4% yield, 3-year raise streak, vs UNH's 2.4%
UNH is the clearest fit if your priority is long-term compounding.
- 220.6% 10Y total return vs CI's 136.5%
CVS is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 0.05, yield 3.1%
- Beta 0.05, yield 3.1%, current ratio 0.84x
- Beta 0.05 vs EHTH's 1.99
- +34.7% vs EHTH's -67.7%
ELV ranks third and is worth considering specifically for growth and efficiency.
- 12.6% revenue growth vs EHTH's 4.1%
- 4.3% ROA vs CVS's 1.1%, ROIC 9.1% vs 5.0%
CI is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 11.3%, EPS growth 82.9%, 3Y rev CAGR 15.1%
- Lower volatility, beta 0.35, Low D/E 75.1%, current ratio 0.85x
- Lower P/E (9.4x vs 13.9x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.6% revenue growth vs EHTH's 4.1% | |
| Value | Lower P/E (9.4x vs 13.9x) | |
| Quality / Margins | Combined ratio 0.9 vs CVS's 1.0 (lower = better underwriting) | |
| Stability / Safety | Beta 0.05 vs EHTH's 1.99 | |
| Dividends | 10.4% yield, 3-year raise streak, vs UNH's 2.4% | |
| Momentum (1Y) | +34.7% vs EHTH's -67.7% | |
| Efficiency (ROA) | 4.3% ROA vs CVS's 1.1%, ROIC 9.1% vs 5.0% |
EHTH vs UNH vs CVS vs ELV vs CI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EHTH vs UNH vs CVS vs ELV vs CI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EHTH leads in 3 of 6 categories
CVS leads 2 • UNH leads 0 • ELV leads 0 • CI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EHTH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 850.3x EHTH's $529M. Profitability is closely matched — net margins range from 3.8% (EHTH) to 0.7% (CVS). On growth, CVS holds the edge at +6.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $529M | $449.7B | $407.9B | $200.4B | $277.9B |
| EBITDAEarnings before interest/tax | $69M | $23.2B | $10.5B | $8.9B | $12.1B |
| Net IncomeAfter-tax profit | $20M | $12.0B | $2.9B | $5.2B | $6.3B |
| Free Cash FlowCash after capex | -$76M | $19.7B | $7.4B | $6.5B | $7.7B |
| Gross MarginGross profit ÷ Revenue | +82.8% | +18.8% | +13.9% | +23.2% | +9.3% |
| Operating MarginEBIT ÷ Revenue | +11.1% | +4.2% | +1.5% | +3.8% | +3.4% |
| Net MarginNet income ÷ Revenue | +3.8% | +2.7% | +0.7% | +2.6% | +2.3% |
| FCF MarginFCF ÷ Revenue | -14.4% | +4.4% | +1.8% | +3.2% | +2.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -22.2% | +2.0% | +6.2% | +2.6% | +4.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +100.0% | +0.7% | +63.1% | -16.8% | +29.1% |
Valuation Metrics
EHTH leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 12.8x trailing earnings, CI trades at a 80% valuation discount to CVS's 62.8x P/E. On an enterprise value basis, EHTH's 1.4x EV/EBITDA is more attractive than UNH's 16.7x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $58M | $335.6B | $111.4B | $81.0B | $74.9B |
| Enterprise ValueMkt cap + debt − cash | $118M | $389.6B | $196.5B | $104.7B | $98.6B |
| Trailing P/EPrice ÷ TTM EPS | -5.47x | 27.95x | 62.81x | 14.84x | 12.81x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.19x | 12.19x | 13.93x | 9.36x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 2.15x | — |
| EV / EBITDAEnterprise value multiple | 1.44x | 16.70x | 13.11x | 10.84x | 8.39x |
| Price / SalesMarket cap ÷ Revenue | 0.10x | 0.75x | 0.28x | 0.41x | 0.27x |
| Price / BookPrice ÷ Book value/share | 0.06x | 3.31x | 1.47x | 1.88x | 1.80x |
| Price / FCFMarket cap ÷ FCF | — | 20.88x | 14.27x | 25.51x | 8.92x |
Profitability & Efficiency
EHTH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CI delivers a 15.1% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $2 for EHTH. EHTH carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVS's 1.24x. On the Piotroski fundamental quality scale (0–9), CI scores 8/9 vs EHTH's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.4% | +11.5% | +3.9% | +11.9% | +15.1% |
| ROA (TTM)Return on assets | +1.7% | +3.9% | +1.1% | +4.3% | +4.1% |
| ROICReturn on invested capital | +6.1% | +9.2% | +5.0% | +9.1% | +10.4% |
| ROCEReturn on capital employed | +6.2% | +9.7% | +6.1% | +8.2% | +9.2% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 | 5 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.14x | 0.77x | 1.24x | 0.75x | 0.75x |
| Net DebtTotal debt minus cash | $61M | $54.0B | $85.1B | $23.7B | $23.8B |
| Cash & Equiv.Liquid assets | $74M | $24.4B | $8.5B | $9.5B | $7.7B |
| Total DebtShort + long-term debt | $134M | $78.4B | $93.6B | $33.2B | $31.5B |
| Interest CoverageEBIT ÷ Interest expense | 15.48x | 4.71x | 2.11x | 5.39x | 6.77x |
Total Returns (Dividends Reinvested)
CVS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CI five years ago would be worth $11,850 today (with dividends reinvested), compared to $270 for EHTH. Over the past 12 months, CVS leads with a +34.7% total return vs EHTH's -67.7%. The 3-year compound annual growth rate (CAGR) favors CVS at 11.0% vs EHTH's -34.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -56.3% | +10.6% | +10.6% | +5.8% | +2.3% |
| 1-Year ReturnPast 12 months | -67.7% | -3.2% | +34.7% | -9.0% | -13.3% |
| 3-Year ReturnCumulative with dividends | -72.2% | -19.9% | +36.6% | -15.6% | +13.6% |
| 5-Year ReturnCumulative with dividends | -97.3% | -2.6% | +17.0% | +1.5% | +18.5% |
| 10-Year ReturnCumulative with dividends | -85.2% | +220.6% | +3.5% | +202.1% | +136.5% |
| CAGR (3Y)Annualised 3-year return | -34.7% | -7.1% | +11.0% | -5.5% | +4.4% |
Risk & Volatility
CVS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CVS is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than EHTH's 1.99 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs EHTH's 26.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.99x | 0.59x | 0.05x | 0.46x | 0.35x |
| 52-Week HighHighest price in past year | $7.09 | $395.52 | $88.63 | $424.24 | $338.89 |
| 52-Week LowLowest price in past year | $1.20 | $234.60 | $58.35 | $273.71 | $239.51 |
| % of 52W HighCurrent price vs 52-week peak | +26.2% | +93.5% | +98.5% | +87.9% | +83.8% |
| RSI (14)Momentum oscillator 0–100 | 61.0 | 75.9 | 69.3 | 75.5 | 53.5 |
| Avg Volume (50D)Average daily shares traded | 754K | 7.9M | 7.4M | 1.9M | 1.5M |
Analyst Outlook
Evenly matched — EHTH and UNH each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: UNH as "Buy", CVS as "Buy", ELV as "Buy", CI as "Buy". Consensus price targets imply 15.5% upside for CI (target: $328) vs 2.5% for ELV (target: $382). For income investors, EHTH offers the higher dividend yield at 10.41% vs ELV's 1.85%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $385.43 | $95.20 | $382.38 | $328.00 |
| # AnalystsCovering analysts | — | 52 | 41 | 37 | 39 |
| Dividend YieldAnnual dividend ÷ price | +10.4% | +2.4% | +3.1% | +1.8% | +2.1% |
| Dividend StreakConsecutive years of raises | 3 | 25 | 0 | 15 | 6 |
| Dividend / ShareAnnual DPS | $0.19 | $8.70 | $2.67 | $6.89 | $6.06 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.2% | +1.7% | 0.0% | +3.2% | +4.8% |
EHTH leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CVS leads in 2 (Total Returns, Risk & Volatility). 1 tied.
EHTH vs UNH vs CVS vs ELV vs CI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EHTH or UNH or CVS or ELV or CI a better buy right now?
For growth investors, Elevance Health Inc.
(ELV) is the stronger pick with 12. 6% revenue growth year-over-year, versus 4. 1% for eHealth, Inc. (EHTH). Cigna Corporation (CI) offers the better valuation at 12. 8x trailing P/E (9. 4x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EHTH or UNH or CVS or ELV or CI?
On trailing P/E, Cigna Corporation (CI) is the cheapest at 12.
8x versus CVS Health Corporation at 62. 8x. On forward P/E, Cigna Corporation is actually cheaper at 9. 4x.
03Which is the better long-term investment — EHTH or UNH or CVS or ELV or CI?
Over the past 5 years, Cigna Corporation (CI) delivered a total return of +18.
5%, compared to -97. 3% for eHealth, Inc. (EHTH). Over 10 years, the gap is even starker: UNH returned +220. 6% versus EHTH's -85. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EHTH or UNH or CVS or ELV or CI?
By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.
05β versus eHealth, Inc. 's 1. 99β — meaning EHTH is approximately 3828% more volatile than CVS relative to the S&P 500. On balance sheet safety, eHealth, Inc. (EHTH) carries a lower debt/equity ratio of 14% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — EHTH or UNH or CVS or ELV or CI?
By revenue growth (latest reported year), Elevance Health Inc.
(ELV) is pulling ahead at 12. 6% versus 4. 1% for eHealth, Inc. (EHTH). On earnings-per-share growth, the picture is similar: Cigna Corporation grew EPS 82. 9% year-over-year, compared to -62. 0% for CVS Health Corporation. Over a 3-year CAGR, CI leads at 15. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EHTH or UNH or CVS or ELV or CI?
eHealth, Inc.
(EHTH) is the more profitable company, earning 7. 2% net margin versus 0. 4% for CVS Health Corporation — meaning it keeps 7. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EHTH leads at 12. 4% versus 2. 6% for CVS. At the gross margin level — before operating expenses — EHTH leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EHTH or UNH or CVS or ELV or CI more undervalued right now?
On forward earnings alone, Cigna Corporation (CI) trades at 9.
4x forward P/E versus 20. 2x for UnitedHealth Group Incorporated — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CI: 15. 5% to $328. 00.
08Which pays a better dividend — EHTH or UNH or CVS or ELV or CI?
All stocks in this comparison pay dividends.
eHealth, Inc. (EHTH) offers the highest yield at 10. 4%, versus 1. 8% for Elevance Health Inc. (ELV).
09Is EHTH or UNH or CVS or ELV or CI better for a retirement portfolio?
For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
05), 3. 1% yield). eHealth, Inc. (EHTH) carries a higher beta of 1. 99 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CVS: +3. 5%, EHTH: -85. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EHTH and UNH and CVS and ELV and CI?
These companies operate in different sectors (EHTH (Financial Services) and UNH (Healthcare) and CVS (Healthcare) and ELV (Healthcare) and CI (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EHTH is a small-cap income-oriented stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock; ELV is a mid-cap deep-value stock; CI is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.